novavax covid-19 - Search News

News

Novavax, Covid-19 and FDA

CNN International on MSN · 1d

FDA may ask Novavax to conduct additional trials of its Covid-19 vaccine to receive full approval

The US Food and Drug Administration has discussed with vaccine-maker Novavax the need for an additional trial of its Covid-19 vaccine as a post-approval commitment, a source familiar with the matter told CNN.

Infectious Disease Advisor · 3h

Novavax COVID-19 Vaccine Moves Closer to Full FDA Approval

Novavax’s COVID-19 vaccine could soon receive full approval from the United States Food and Drug Administration.

Reuters on MSN · 2d

US FDA asks Novavax to complete new clinical trial for delayed COVID-19 shot, WSJ reports

Federal regulators have asked Novavax to complete an additional clinical trial on its COVID-19 vaccine after previously delaying approval, the Wall Street Journal reported on Friday, citing people familiar with the matter.

32mon MSN

Novavax Stock Is Up Again on Speculation Over the Fate of Its Covid Shot

Novavax stock was climbing again on Monday after the company expressed new confidence in the eventual approval of its ...

3h

Novavax: Grandiose Ambitions, Smart Strategy, But FDA Decision Adds To Challenges

Novavax shows financial improvement but faces vaccine challenges. Read why I rated NVAX stock as 'Hold' and what risks and ...

Devdiscourse19h

Global Health Dynamics: From Ebola to COVID-19 Developments

A summary of current health news, including the disbanding of a U.S. Justice Department unit focusing on food and drug safety ...

2don MSN

FDA asks Novavax to complete new clinical trial for delayed COVID-19 shot, WSJ reports

(Reuters) -Federal regulators have asked Novavax to complete an additional clinical trial on its COVID-19 vaccine after ...

Zacks.com on MSN4d

Novavax (NVAX) Surges 19.5%: Is This an Indication of Further Gains?

Novavax (NVAX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings ...

Novavax Booster's Fate in Limbo: FDA Considers Approval Amid Controversy

The FDA is considering the approval of the Novavax COVID-19 booster after delays amid controversy over its non-mRNA design.

4d

Novavax's stock surges on 'good news' from Food and Drug Administration

Novavax’s protein-based vaccine is only available under a pandemic-era emergency-use authorization, and formal approval from ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

"%24%20is%20not%20defined","Stack":"ReferenceError%3A%20%24%20is%20not%20defined%0A%20%20%20%20at%20self%3A59%3A3529%0A%20%20%20%20at%20self%3A59%3A3535","Meta":"self","Line":"59","Char":"3529"